Nwam LLC Acquires Shares of 10,313 Xylem Inc. $XYL

Nwam LLC bought a new position in shares of Xylem Inc. (NYSE:XYL) during the first quarter, according to its most recent filing with the SEC. The fund bought 10,313 shares of the industrial products company’s stock, valued at approximately $1,232,000.

Several other institutional investors also recently added to or reduced their stakes in the stock. Wexford Capital LP bought a new stake in shares of Xylem in the 3rd quarter worth approximately $27,000. Commonwealth Retirement Investments LLC purchased a new stake in Xylem in the fourth quarter worth $27,000. Board of the Pension Protection Fund purchased a new stake in Xylem in the fourth quarter worth $27,000. Entrust Financial LLC bought a new stake in shares of Xylem in the fourth quarter valued at $45,000. Finally, FWL Investment Management LLC purchased a new position in shares of Xylem during the 2nd quarter valued at $43,000. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of NYSE XYL opened at $125.18 on Friday. The stock’s 50-day simple moving average is $113.04 and its two-hundred day simple moving average is $123.48. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The firm has a market capitalization of $29.75 billion, a P/E ratio of 31.14, a P/E/G ratio of 1.73 and a beta of 1.03. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same period in the prior year, the business earned $1.03 earnings per share. Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, equities analysts anticipate that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is currently 42.79%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on XYL shares. Oppenheimer cut their price target on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Royal Bank Of Canada upped their price objective on shares of Xylem from $157.00 to $159.00 and gave the company an “outperform” rating in a report on Thursday. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and increased their target price for the stock from $130.00 to $140.00 in a research report on Thursday, June 25th. Stifel Nicolaus lowered their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, Weiss Ratings cut shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Eight investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $153.31.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of Xylem stock in a transaction on Monday, May 4th. The shares were acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by corporate insiders.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.